← Back to Search

Patient education bundle (PEB) for Deep Vein Thrombosis (ENACT Trial)

N/A
Waitlist Available
Led By Elliott R Haut, MD. PhD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

ENACT Trial Summary

This trial will compare the effect of a patient education bundle (PEB) to a program of nurse feedback and coaching (NFC) on preventing VTE among hospitalized patients.

Eligible Conditions
  • Deep Vein Thrombosis (DVT)

ENACT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Missed doses of VTE prophylaxis
Secondary outcome measures
Missed doses of VTE prophylaxis for reasons other than patient refusal
Nurse Satisfaction
Patient refused doses of VTE prophylaxis
+2 more

ENACT Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Patient education bundle (PEB)Active Control1 Intervention
A charge nurse will intervene in real-time via an EHR-triggered alert when there is documentation that a dose of VTE prophylaxis medication is not given for any reason. The charge nurse will speak to the bedside nurse and one of them will provide the patient with the education bundle including one-on-one personalized discussion, supplemented by a 2-page paper handout and patient education video.
Group II: Nurse feedback and coaching (NFC)Placebo Group1 Intervention
Nurse leadership (i.e. managers, directors) will provide data to all nurses on their personal clinical effectiveness with the proportion of doses of VTE prophylaxis administered. The data will have comparisons to their nurse peers on the same floor. Coaching for nurses will include one-on-one conversations with bedside nurses with lower performance than their peers.

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,262 Previous Clinical Trials
14,813,507 Total Patients Enrolled
4 Trials studying Deep Vein Thrombosis
20,351 Patients Enrolled for Deep Vein Thrombosis
Patient-Centered Outcomes Research InstituteOTHER
550 Previous Clinical Trials
29,987,291 Total Patients Enrolled
3 Trials studying Deep Vein Thrombosis
436,463 Patients Enrolled for Deep Vein Thrombosis
Elliott R Haut, MD. PhDPrincipal InvestigatorJohns Hopkins University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this clinical trial still have capacity to accept new participants?

"As per the records on clinicaltrials.gov, this particular study is no longer accepting new participants. It was first posted in January 1st 2018 and its last update happened on December 8th 2021. However, there are 200 other trials actively searching for patients at present time."

Answered by AI
Recent research and studies
JAMA SurgeryJournal
Preventability of Hospital-acquired Venous Thromboembolism
Haut, Elliott R., Brandyn D. Lau, Peggy S. Kraus, Deborah B. Hobson, Bhunesh Maheshwari, Peter J. Pronovost, and Michael B. Streiff. 2015. “Preventability of Hospital-acquired Venous Thromboembolism”. JAMA Surgery. American Medical Association (AMA). doi:10.1001/jamasurg.2015.1340.
Plos OneJournal
Effectiveness of Two Distinct Web-based Education Tools for Bedside Nurses on Medication Administration Practice for Venous Thromboembolism Prevention: A Randomized Clinical Trial
Lau, Brandyn D., Dauryne L. Shaffer, Deborah B. Hobson, Gayane Yenokyan, Jiangxia Wang, Elizabeth A. Sugar, Joseph K. Canner, et al.. 2017. “Effectiveness of Two Distinct Web-based Education Tools for Bedside Nurses on Medication Administration Practice for Venous Thromboembolism Prevention: A Randomized Clinical Trial”. Edited by Christophe Leroyer. Plos One. Public Library of Science (PLoS). doi:10.1371/journal.pone.0181664.
Journal of General Internal MedicineJournal
Missed Doses of Venous Thromboembolism (VTE) Prophylaxis at Community Hospitals: Cause for Alarm
Lau, Brandyn D., Michael B. Streiff, Peggy S. Kraus, Deborah B. Hobson, Dauryne L. Shaffer, Jonathan K. Aboagye, Peter J. Pronovost, and Elliott R. Haut. 2017. “Missed Doses of Venous Thromboembolism (VTE) Prophylaxis at Community Hospitals: Cause for Alarm”. Journal of General Internal Medicine. Springer Science and Business Media LLC. doi:10.1007/s11606-017-4203-y.
PLoS ONEJournal
Patterns of Non-administration of Ordered Doses of Venous Thromboembolism Prophylaxis: Implications for Novel Intervention Strategies
Shermock, Kenneth M., Brandyn D. Lau, Elliott R. Haut, Deborah B. Hobson, Valerie S. Ganetsky, Peggy S. Kraus, Leigh E. Efird, et al.. 2013. “Patterns of Non-administration of Ordered Doses of Venous Thromboembolism Prophylaxis: Implications for Novel Intervention Strategies”. Edited by Farah Magrabi. Plos ONE. Public Library of Science (PLoS). doi:10.1371/journal.pone.0066311.
~1332 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top